tau in alzh - is it real? what exactly did Biogen say?

Research evidence excerpt

tau in alzh - is it real? what exactly did Biogen say?

May 14, 2026

VALUATION METHODOLOGY

Valuation is based on a blend of SOTP and DCF methodologies.

RISKS

Regulatory, commercial, and legal, including potential delays to pipeline development, generic entry to established products,

changes in drug pricing, changes in tax law, loss of patent exclusivity through unfavourable litigation outcomes, and/or poor M&A

execution/integration.

COMPANIES UNDER COVERAGE BY AUTHOR

Price Evercore ISI

Symbol Company Rating (2026-14-05) Target

ALKS Alkermes plc Outperform $38.44

AMGN Amgen Inc Outperform $336.30

BHC Bausch Health Companies Inc In Line $5.45

BIIB Biogen Inc. Outperform $190.70

Rating

BMY Bristol Myers Squibb Suspended $56.67

CNTA Centessa Pharmaceuticals PLC Outperform $39.60

CVAC CureVac N.V. Outperform $4.66

ELAN Elanco Animal Health Incorporated Outperform $21.75

EVMN Evommune, Inc Outperform $22.48 $55.00

GILD Gilead Sciences Inc Outperform $131.93

GUTS Fractyl Health, Inc. Outperform $0.93

JAZZ Jazz Pharmaceuticals plc Suspended $231.59

KLRA Kailera Therapeutics, Inc Outperform $21.72

KOD Kodiak Sciences Inc Outperform $38.48

LEGN Legend Biotech Corp. Outperform $28.70

LLY Eli Lilly & Co. In Line $1008.16

MGNX Macrogenics Inc Outperform $4.13

MLYS Mineralys Therapeutics, Inc. Outperform $27.09

MRK Merck & Co Inc Outperform $113.22

MTSR Metsera, Inc. Outperform $70.50

OGN Organon & Co. In Line $13.37

PCVX Vaxcyte, Inc Outperform $53.49

PFE Pfizer Inc. Outperform $25.73

PHAT Phathom Pharmaceuticals, Inc. Outperform $12.99

PROK ProKidney Corp. In Line $1.72

PRTA Prothena Corp. Suspended $9.77

RAPT RAPT Therapeutics, Inc. Suspended $58.02

RCUS Arcus Biosciences, Inc Outperform $24.90 $33.00

RPRX Royalty Pharma In Line $53.37

SYRE Spyre Therapeutics, Inc.